These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36682941)

  • 1. Genetic testing in dyslipidaemia: An approach based on clinical experience.
    Berberich AJ; Hegele RA
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101720. PubMed ID: 36682941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disorders.
    Berberich AJ; Hegele RA
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101719. PubMed ID: 36641373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Trinder M; Brunham LR
    Curr Opin Lipidol; 2021 Apr; 32(2):103-111. PubMed ID: 33395106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic risk scores for the diagnosis and management of dyslipidemia.
    Brunham LR; Trinder M
    Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):95-100. PubMed ID: 35034034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Modern Approach to Dyslipidemia.
    Berberich AJ; Hegele RA
    Endocr Rev; 2022 Jul; 43(4):611-653. PubMed ID: 34676866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
    Brown EE; Sturm AC; Cuchel M; Braun LT; Duell PB; Underberg JA; Jacobson TA; Hegele RA
    J Clin Lipidol; 2020; 14(4):398-413. PubMed ID: 32507592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
    Pitso L; Mofokeng TRP; Nel R
    BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum dyslipidaemia in women diagnosed with gestational diabetes mellitus.
    O'Higgins AC; O'Dwyer V; O'Connor C; Daly SF; Kinsley BT; Turner MJ
    Ir J Med Sci; 2017 May; 186(2):403-407. PubMed ID: 27401735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
    Wang J; Dron JS; Ban MR; Robinson JF; McIntyre AD; Alazzam M; Zhao PJ; Dilliott AA; Cao H; Huff MW; Rhainds D; Low-Kam C; Dubé MP; Lettre G; Tardif JC; Hegele RA
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2439-2445. PubMed ID: 27765764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMIP SNPs and their haplotypes are associated with dyslipidaemia and clinicopathologic features of IgA nephropathy.
    Pan L; Liao YH; Mo MQ; Zhang QH; Yin RX
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in LCAT may contribute to dyslipidaemia in HIV-infected individuals on HAART in a Ghanaian population.
    Bani SB; Danquah KO; Obirikorang C; Owiredu WKBA; Quaye L; Muonir Der E; Acheampong E; Adams Y; Dapare PPM; Banyeh M; Anto EO; Sakyi SA
    Sci Rep; 2020 Nov; 10(1):19419. PubMed ID: 33173066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C.
    Jakubowski B; Shao Y; McNeal C; Xing C; Ahmad Z
    J Clin Lipidol; 2021; 15(5):658-664. PubMed ID: 34340953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors increase the identification efficiency of predictive models for dyslipidaemia: a prospective cohort study.
    Niu M; Zhang L; Wang Y; Tu R; Liu X; Hou J; Huo W; Mao Z; Wang Z; Wang C
    Lipids Health Dis; 2021 Feb; 20(1):11. PubMed ID: 33579296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine.
    Peterlin A; Petrovič D; Peterlin B
    Curr Vasc Pharmacol; 2019; 17(1):25-28. PubMed ID: 29412113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of atherogenic dyslipidaemia in clinical practice guidelines].
    Pedro-Botet J; Mantilla-Morató T; Díaz-Rodríguez Á; Brea-Hernando Á; González-Santos P; Hernández-Mijares A; Pintó X; Millán Núñez-Cortés J
    Clin Investig Arterioscler; 2016; 28(2):65-70. PubMed ID: 26949069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the molecular biology of dyslipidemias.
    Ramasamy I
    Clin Chim Acta; 2016 Feb; 454():143-85. PubMed ID: 26546829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
    Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA
    BMC Med Genomics; 2020 Feb; 13(1):23. PubMed ID: 32041611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in the association between lipid metabolism genes and lipid levels in black and white South African women.
    Ellman N; Keswell D; Collins M; Tootla M; Goedecke JH
    Atherosclerosis; 2015 Jun; 240(2):311-7. PubMed ID: 25864161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
    Park YJ; Yoo SA; Lee JH; Chung YJ; Cho CS; Kim W-
    Clin Exp Rheumatol; 2013; 31(2):180-8. PubMed ID: 23190940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.